PDF-Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch

Author : daniella | Published Date : 2021-06-18

wwwRxFilesca June 2021 Drug BRAND Vitamin K Antagonist DOACs Comments There is a positive correlation between warfarin

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Nonvalvular Atrial Fibrillation Anticoag..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch: Transcript

wwwRxFilesca June 2021 Drug BRAND Vitamin K Antagonist DOACs Comments There is a positive correlation between warfarin. Mortality Risks . in . Elderly Medicare Beneficiaries . Treated . with Dabigatran . or Rivaroxaban . for . Nonvalvular. Atrial Fibrillation. To compare risks of thromboembolic stroke, intracranial hemorrhage, major . Percutaneous. Left Atrial Appendage (LAA) Exclusion. Aaditya Vora, MD. Cardiac Electrophysiologist. Baptist heart specialists. Disclosures. None. > . 33M. people with . AF Worldwide. 1. Many patients are unprotected. Rhea C. Pimentel, MD. Associate Professor of Medicine. Fellowship Program Director, Clinical Cardiac Electrophysiology Program. Disclosures. Speakers Bureau: Medtronic. Speakers Bureau: St. Jude Medical. Martha Drake MS, FNP-BC. Chicago Heart and Vascular Consultants, LTD. Purdue Northwest Doctorate of Nursing Program. Learning Objectives. Discuss the incidence of atrial fibrillation (AF) in the population. Fibrillation. Michelle Tsukamoto . DSR 2 May 9, 2018. PGY 2. 1. Objectives. Discuss which patients with . atrial. fibrillation should be . anticoagulated. for CVA prevention. Learn about different oral anticoagulation options . . John Windle MD October 18, 2013. Professor and Chief of Cardiology. University of Nebraska Medical Center. “Ha . ha. . ha. , Biff. Guess what? After we go to the drugstore and the post office, . Fibrillation. Michelle Tsukamoto . DSR 2 May 9, 2018. PGY 2. 1. Objectives. Discuss which patients with . atrial. fibrillation should be . anticoagulated. for CVA prevention. Learn about different oral anticoagulation options . Jennie Hsu-. Lumetta. , MD, FACP. Corinne Kohler, . MD, FAAFP. Narain. . Mandhan. , MD, FACP, FASAM. Karen . Wiarda. , . DO. Muhammad . Ajmal. , . MD, PGY 3 Chief. ACP QI . Project. Atrial Fibrillation . Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . . John Windle MD October 18, 2013. Professor and Chief of Cardiology. University of Nebraska Medical Center. “Ha . ha. . ha. , Biff. Guess what? After we go to the drugstore and the post office, . Carlos Calle-Muller, MD. Cardiac Electrophysiology. 734-855-9448. Objectives. To recognize the risks for patients with atrial fibrillation. To familiarize with the management of atrial fibrillation. Atrial fibrillation (AF) is the most common cardiac arrhythmia . rivaroxaban. group vs. 1.02% of the vitamin K antagonist group (p = . NS). Major bleeding: 0.61% of the . rivaroxaban. group vs. 0.80% of the placebo group (p = . NS). Trial design:. . Participants with .

Download Document

Here is the link to download the presentation.
"Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.